[allAfrica] The recent decision by the U.S. Food and Drug Administration (FDA) to authorize the marketing of 20 ZYN nicotine pouch products is a landmark moment in the global conversation on tobacco harm reduction. This milestone underscores the growing potential of smoke-free alternatives to transform public health outcomes, particularly in regions like Africa, where tobacco-related diseases continue to be a pressing concern.
Source